MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 15, 2004; DOI: 10.1124/mol.104.004846


0026-895X/05/6703-721-733$20.00
Mol Pharmacol 67:721-733, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.104.004846v1
67/3/721    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baurand, A.
Right arrow Articles by Gachet, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baurand, A.
Right arrow Articles by Gachet, C.
ORIGINAL ARTICLE

Differential Regulation and Relocalization of the Platelet P2Y Receptors after Activation: A Way to Avoid Loss of Hemostatic Properties?{boxs}

Anthony Baurand, Anita Eckly, Béatrice Hechler, Gilles Kauffenstein, Jean-Luc Galzi, Jean-Pierre Cazenave, Catherine Léon, and Christian Gachet

Laboratoire de Biologie et de Pharmacologie de l'Hémostase et de la Thrombose, Institut National de la Santé et de la Recherche Médicale U.311, Etablissement Français du Sang-Alsace, Strasbourg Cedex, France (A.B., A.E., B.H., G.K., J.-P.C., C.L., C.G.); and Département Récepteurs et Protéines Membranaires, Unité Propre de Recherche Centre National de la Recherche Scientifique 9050, Institut Fédératif Gilbert Laustriat, l'Institut Fédératif de Recherches 85, Ecole Supérieure de Biotechnologie de Strasbourg, Illkirch, France (J.-L.G.)

Abstract

In the present study, we investigated the desensitization and trafficking of the P2Y1 and P2Y12 receptors after agonist-induced stimulation of platelets or astrocytoma cells transfected with the P2Y1 or P2Y12 receptors fused to green fluorescent protein. In platelets and in transfected cells, exposure to 10 µM ADP caused desensitization of the P2Y1 receptor-driven calcium signal, whereas the P2Y12 receptor-mediated inhibition of cAMP formation was not affected. Plasma membranes from ADP-stimulated platelets also retained P2Y12 activity. Agonist-induced P2Y1 receptor desensitization was accompanied by its internalization in platelets and transfected cells. In contrast, although a substantial fraction of P2Y12 receptors was rapidly and transiently internalized, most of the P2Y12 receptors remained at the plasma membrane. Activated P2Y1 receptors were internalized through a clathrin-dependent pathway in cells and platelets, whereas the P2Y12 receptors seemed to use a distinct, clathrin-independent pathway. Together, these data indicate that the P2Y1 and P2Y12 receptors are differentially regulated upon activation. The absence of desensitization of the Gi protein-coupled P2Y12 receptor-dependent responses could represent a mechanism to preserve the hemostatic properties of otherwise unresponsive platelets.


Received July 9, 2004; accepted December 14, 2004

Address correspondence to: Dr. Christian Gachet, Laboratoire de Biologie et de Pharmacologie de l'Hémostase et de la Thrombose, INSERM U.311, Etablissement Français du Sang-Alsace, 10 rue Spielmann, BP 36, 67065 Strasbourg Cedex, France. E-mail:christian.gachet{at}efs-alsace.fr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. C. Y. Choi, J. Simon, K. W. K. Tsim, and E. A. Barnard
Constitutive and Agonist-induced Dimerizations of the P2Y1 Receptor: RELATIONSHIP TO INTERNALIZATION AND SCAFFOLDING
J. Biol. Chem., April 18, 2008; 283(16): 11050 - 11063.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. Cattaneo, A. Lecchi, M. L. Zighetti, and F. Lussana
Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count
Haematologica, May 1, 2007; 92(5): 694 - 697.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al.
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Mundell, M. L. Jones, A. R. Hardy, J. F. Barton, S. M. Beaucourt, P. B. Conley, and A. W. Poole
Distinct Roles for Protein Kinase C Isoforms in Regulating Platelet Purinergic Receptor Function
Mol. Pharmacol., September 1, 2006; 70(3): 1132 - 1142.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics